Never Breastfeeding Linked to Increased Risk of T1DM

Share this content:
Never Breastfeeding Linked to Increased Risk of T1DM
Never Breastfeeding Linked to Increased Risk of T1DM

FRIDAY, May 12, 2017 (HealthDay News) -- Never breastfeeding seems to be associated with increased risk of type 1 diabetes, according to a study published online May 9 in Diabetes Care.

Nicolai A. Lund-Blix, from Oslo University Hospital in Norway, and colleagues followed two population-based cohorts of children from birth (1996 to 2009) to 2014 or 2015 (Denmark or Norway). Data were analyzed for 155,392 children. Infant dietary practices at age 6 to 18 months were reported by parents.

The researchers identified type 1 diabetes in 504 children during follow-up, with the incidence of type 1 diabetes being 30.5 and 23.5 per 100,000 person-years in the Norwegian and Danish cohorts, respectively. The risk of type 1 diabetes was increased two-fold for children who were never breastfed versus those who were breastfed (hazard ratio, 2.29; 95 percent confidence interval, 1.14 to 4.61). The incidence of type 1 diabetes was independent of duration of full breastfeeding (hazard ratio per month, 0.99; 95 percent confidence interval, 0.97 to 1.01) and of any breastfeeding (hazard ratio per month, 0.97; 95 percent confidence interval, 0.92 to 1.03) among those who were breastfed.

"Suggestive evidence supports the contention that breastfeeding reduces the risk of type 1 diabetes," the authors write. "Among those who were breastfed, however, no evidence indicated that prolonging full or any breastfeeding was associated with a reduced risk of type 1 diabetes."

The study was partially funded by the Novo Nordisk Foundation.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »